-
EP2894165
European procedure
Extract from the Register of European Patents
EP About this file: EP2894165
| EP2894165 - Methods and compositions for treating complement-associated disorders [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 02.12.2022 Database last updated on 03.04.2025 | |
| Former | Grant of patent is intended Status updated on 29.09.2022 | ||
| Former | Examination is in progress Status updated on 16.08.2022 | ||
| Former | Grant of patent is intended Status updated on 11.04.2022 | ||
| Former | Examination is in progress Status updated on 23.12.2016 | Most recent event Tooltip | 21.02.2025 | Change - opposition data/opponents data or that of the opponents representative | published on 26.03.2025 [2025/13] | Applicant(s) | For all designated states ALEXION PHARMACEUTICALS, INC. 121 Seaport Boulevard Boston, MA 02210 / US | [2022/52] |
| Former [2015/29] | For all designated states ALEXION PHARMACEUTICALS, INC. 352 Knotter Drive Cheshire, CT 06410 / US | Inventor(s) | 01 /
Rother, Russell, P. 10325 Forest Meadow Drive Oklahoma City, OK 73151 / US | 02 /
Bedrosian, Camille 22 Lantern Road Belmont, MA 02478 / US | 03 /
Squinto, Stephen, P. 16 Coachmans Lane Bethnay, CT 06524 / US | 04 /
Bell, Leonard 59 Tumblebrook Road Woodbridge, CT 06525 / US | [2015/29] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2015/29] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 15152757.9 | 10.11.2009 | [2015/29] | Priority number, date | US20080198803P | 10.11.2008 Original published format: US 198803 P | US20080199563P | 18.11.2008 Original published format: US 199563 P | US20080199569P | 18.11.2008 Original published format: US 199569 P | US20080199562P | 18.11.2008 Original published format: US 199562 P | US20080199764P | 19.11.2008 Original published format: US 199764 P | US20080200634P | 01.12.2008 Original published format: US 200634 P | US20080200635P | 01.12.2008 Original published format: US 200635 P | US20080200640P | 01.12.2008 Original published format: US 200640 P | US20090181788P | 28.05.2009 Original published format: US 181788 P | US20090228047P | 23.07.2009 Original published format: US 228047 P | [2015/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2894165 | Date: | 15.07.2015 | Language: | EN | [2015/29] | Type: | B1 Patent specification | No.: | EP2894165 | Date: | 04.01.2023 | Language: | EN | [2023/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.05.2015 | Classification | IPC: | C07K16/18 | [2015/29] | CPC: |
C07K16/18 (EP,KR,US);
A61K38/00 (EP,KR,US);
A61K38/16 (KR);
A61K38/19 (KR);
A61K39/395 (KR);
A61K39/3955 (US);
A61K45/06 (US);
A61K9/0019 (US);
A61P13/12 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
A61P9/00 (EP);
A61P9/12 (EP);
A61P9/14 (EP);
A61K2039/505 (EP,KR,US);
A61K2039/54 (US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/09] |
| Former [2015/29] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Extension states | AL | 15.01.2016 | BA | 15.01.2016 | RS | 15.01.2016 | Title | German: | Verfahren und Zusammensetzungen zur Behandlung von komplementassoziierten Störungen | [2015/29] | English: | Methods and compositions for treating complement-associated disorders | [2015/29] | French: | Procédés et compositions pour le traitement de troubles associés à un complément | [2015/29] | Examination procedure | 15.01.2016 | Amendment by applicant (claims and/or description) | 15.01.2016 | Examination requested [2016/09] | 02.01.2017 | Despatch of a communication from the examining division (Time limit: M04) | 12.05.2017 | Reply to a communication from the examining division | 19.07.2018 | Date of oral proceedings | 02.08.2018 | Despatch of communication that the application is refused, reason: substantive examination {1} | 02.08.2018 | Minutes of oral proceedings despatched | 24.09.2021 | Despatch of a communication from the examining division (Time limit: M04) | 04.02.2022 | Reply to a communication from the examining division | 12.04.2022 | Communication of intention to grant the patent | 12.08.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 30.09.2022 | Communication of intention to grant the patent | 17.11.2022 | Fee for grant paid | 17.11.2022 | Fee for publishing/printing paid | 17.11.2022 | Receipt of the translation of the claim(s) | Appeal following examination | 01.10.2018 | Appeal received No. T0033/19 | 12.12.2018 | Statement of grounds filed | 22.04.2021 | Result of appeal procedure: continuation of examination procedure | 01.06.2021 | Despatch of the decision of the Board of Appeal | Parent application(s) Tooltip | EP09825611.8 / EP2352517 | Divisional application(s) | EP21169657.0 / EP3974448 | Opposition(s) | Opponent(s) | 01
17.05.2023
19.05.2023
ADMISSIBLE Amgen Technology (Ireland) Unlimited Company Pottery Road Dun Laoghaire A96 F2A8 Dublin / IE Opponent's representative Dörries, Hans Ulrich df-mp Patentanwälte Rechtsanwälte PartG mbB Theatinerstraße 16 80333 München / DE | 02
04.10.2023
06.10.2023
ADMISSIBLE Samsung Bioepis Co., Ltd. 76, Songdogyoyuk-ro Yeonsu-gu Incheon 21987 / KR Opponent's representative Simmons & Simmons LLP (Munich) Lehel Carré Gewürzmühlstraße 11 80538 Munich / DE | [2025/13] |
| Former [2024/41] | |||
| Opponent(s) | 01
17.05.2023
19.05.2023
ADMISSIBLE Amgen Technology (Ireland) Unlimited Company Pottery Road Dun Laoghaire A96 F2A8 Dublin / IE Opponent's representative Dörries, Hans Ulrich df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | ||
| 02
04.10.2023
06.10.2023
ADMISSIBLE Samsung Bioepis Co., Ltd. 76, Songdogyoyuk-ro Yeonsu-gu Incheon 21987 / KR Opponent's representative Simmons & Simmons LLP (Munich) Lehel Carré Thierschplatz 6 80538 Munich / DE | |||
| Former [2023/46] | |||
| Opponent(s) | 01
17.05.2023
19.05.2023
ADMISSIBLE Amgen Technology (Ireland) Unlimited Company Pottery Road Dun Laoghaire A96 F2A8 Dublin / IE Opponent's representative Dörries, Hans Ulrich df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | ||
| 02
04.10.2023
06.10.2023
ADMISSIBLE Samsung Bioepis Co., Ltd. 76, Songdogyoyuk-ro Yeonsu-gu Incheon 21987 / KR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | |||
| Former [2023/26] | |||
| Opponent(s) | 01
17.05.2023
19.05.2023
ADMISSIBLE Amgen Technology (Ireland) Unlimited Company Pottery Road Dun Laoghaire A96 F2A8 Dublin / IE Opponent's representative Dörries, Hans Ulrich df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | ||
| Former [2023/25] | |||
| Opponent(s) | 01
17.05.2023
Amgen Technology (Ireland) Unlimited Company Pottery Road Dun Laoghaire A96 F2A8 Dublin / IE Opponent's representative Dörries, Hans Ulrich df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | 16.10.2023 | Invitation to proprietor to file observations on the notice of opposition | 26.02.2024 | Reply of patent proprietor to notice(s) of opposition | 19.09.2024 | Despatch of a communication from the opposition division (Time limit: M04) | 12.05.2025 | Date of oral proceedings | Fees paid | Renewal fee | 27.01.2015 | Renewal fee patent year 03 | 27.01.2015 | Renewal fee patent year 04 | 27.01.2015 | Renewal fee patent year 05 | 27.01.2015 | Renewal fee patent year 06 | 30.11.2015 | Renewal fee patent year 07 | 28.11.2016 | Renewal fee patent year 08 | 27.11.2017 | Renewal fee patent year 09 | 27.11.2018 | Renewal fee patent year 10 | 27.11.2019 | Renewal fee patent year 11 | 27.11.2020 | Renewal fee patent year 12 | 29.11.2021 | Renewal fee patent year 13 | 28.11.2022 | Renewal fee patent year 14 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | NL | 04.01.2023 | GB | 25.10.2023 | [2024/34] |
| Former [2024/24] | GB | 25.10.2023 | Documents cited: | Search | [Y]US2005191298 (BELL LEONARD [US], et al); | by applicant | US3710795 | US4376110 | US4634666 | US4676980 | US4686100 | WO8806630 | WO8902468 | US4816567 | WO8905345 | WO8907136 | US4863457 | US4868116 | US4980286 | US4987071 | EP0430539 | US5093246 | WO9203918 | WO9207573 | US5116742 | EP0488401 | WO9215679 | WO9222645 | WO9222647 | WO9222670 | WO9312227 | US5223409 | US5225539 | WO9400569 | WO9402602 | WO9425585 | US5403484 | US5427908 | US5501856 | US5508717 | WO9614436 | EP0463151 | US5545807 | US5545806 | WO9627011 | US5569825 | WO9634096 | US5571698 | US5591669 | WO9708320 | US5612205 | WO9713852 | US5625825 | US5625126 | US5633425 | US5643763 | US5661016 | EP0546073 | US5721367 | WO9824893 | WO9824884 | US5770429 | US5780279 | US5789650 | US5789215 | US5814318 | US5874299 | US5877397 | US5939598 | US5997848 | US6019968 | US6040136 | US6075181 | WO0034317 | US6114598 | WO0061178 | US6150584 | WO0069887 | US6162963 | WO0115731 | US6255458 | US6300129 | US6355245 | WO02069232 | US2003143204 | US2003166282 | US6657103 | US2003224432 | US2003229905 | US6673986 | US2004010810 | US6680209 | US2004038278 | US6713610 | US2004093622 | US6794132 | WO2004108158 | US2005054055 | US6866845 | US2005076395 | US2005287630 | US2006040363 | US7041871 | US7056897 | US2006153836 | US2006160726 | US7112341 | WO2006122257 | WO2007024715 | US2007172483 | US2007235029 | WO2008024188 | US7393648 | US2008202513 | US2008241223 | Opposition | WO2010054403 | EP2894165 |